SOPHiA GENETICS SA Stock Börse Stuttgart
Stocks
90B
CH1125843347
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.450 EUR | +10.77% |
|
+13.07% | +40.46% |
| 08-05 | SOPHiA GENETICS SA, Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies | CI |
| Market Cap | 536M 464M 433M 398M 752M 51B 760M 5.09B 2B 25.52B 2.01B 1.97B 84.51B | P/E 2026 * |
-6.8x | P/E 2027 * | -10x |
|---|---|---|---|---|---|
| Enterprise Value | 536M 464M 433M 398M 752M 51B 760M 5.09B 2B 25.52B 2.01B 1.97B 84.51B | EV / Sales 2026 * |
5.65x | EV / Sales 2027 * | 4.58x |
| Free-Float |
76.9% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SOPHiA GENETICS SA
| 1 day | +10.77% | ||
| 1 week | +13.07% | ||
| Current month | +11.68% | ||
| 1 month | +17.97% | ||
| 3 months | +25.00% | ||
| 6 months | +39.74% | ||
| Current year | +40.46% |
| 1 week | 4.8 |  | 6.15 |
| 1 month | 4.74 | | 6.15 |
| Current year | 3.46 | | 6.15 |
| 1 year | 3.34 | | 6.15 |
| 3 years | 2.08 | | 6.15 |
| 5 years | 2.08 | | 6.15 |
| 10 years | 2.08 | | 6.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ross Muken
CEO | Chief Executive Officer | 46 | 01/07/2026 |
George Cardoza
DFI | Director of Finance/CFO | 64 | 05/11/2024 |
Abhimanyu Verma
CTO | Chief Tech/Sci/R&D Officer | - | 10/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jurgi Camblong
CHM | Chairman | 47 | 22/06/2026 |
Vincent Ossipow
BRD | Director/Board Member | 57 | 01/06/2014 |
Troy Cox
CHM | Chairman | 61 | 01/02/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.77% | +13.07% | - | - | 574M | |
| +0.78% | +2.69% | -24.14% | +8.42% | 34.42B | |
| -1.55% | +10.17% | -44.62% | +149.25% | 12.7B | |
| -0.37% | -5.44% | -24.18% | +64.70% | 5.43B | |
| -0.40% | +8.51% | - | - | 2.35B | |
| +1.47% | +10.78% | - | - | 1.83B | |
| +0.05% | -10.22% | +21.87% | -42.80% | 1.69B | |
| +3.17% | +6.23% | -34.13% | - | 1.06B | |
| +4.52% | +7.69% | +35.48% | +115.89% | 873M | |
| -0.27% | +8.85% | -38.09% | -48.82% | 849M | |
| Average | +1.80% | +4.12% | -15.40% | +41.11% | 6.8B | |
| Weighted average by Cap. | +0.29% | +3.13% | -26.82% | +45.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 94.92M 82.21M 76.63M 70.48M 133M 9.03B 135M 901M 353M 4.52B 356M 349M 14.96B | 117M 101M 94.58M 86.99M 164M 11.14B 166M 1.11B 436M 5.57B 440M 430M 18.46B |
| Net income | -72.67M -62.94M -58.67M -53.96M -102M -6.91B -103M -689M -271M -3.46B -273M -267M -11.45B | -49.83M -43.16M -40.23M -37M -69.85M -4.74B -70.63M -473M -186M -2.37B -187M -183M -7.85B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 05/08/26 | €5.450 | +10.77% |
| 04/08/26 | €4.920 | -1.20% |
| 03/08/26 | €4.980 | +2.05% |
| 31/07/26 | €4.880 | -2.01% |
| 30/07/26 | €4.980 | +3.32% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SOPH Stock
- 90B Stock
Select your edition
All financial news and data tailored to specific country editions
